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Genetic studies have identified dozens of autism
spectrumdisorder (ASD) susceptibility genes, raising
two critical questions: (1) do these genetic loci
converge on specific biological processes, and (2)
where does the phenotypic specificity of ASD arise,
given its genetic overlap with intellectual disability
(ID)? To address this, we mapped ASD and ID risk
genes onto coexpression networks representing
developmental trajectories and transcriptional pro-
files representing fetal and adult cortical laminae.
ASD genes tightly coalesce in modules that implicate
distinct biological functions during human cortical
development, including early transcriptional regula-
tion and synaptic development. Bioinformatic ana-
lyses suggest that translational regulation by FMRP
and transcriptional coregulation by common tran-
scription factors connect these processes. At a cir-
cuit level, ASD genes are enriched in superficial
cortical layers and glutamatergic projection neurons.
Furthermore, we show that the patterns of ASD and
ID risk genes are distinct, providing a biological
framework for further investigating the pathophysi-
ology of ASD.INTRODUCTION
Autism spectrum disorder (ASD) is a heterogeneous neurodeve-
lopmental disorder in which hundreds of genes have been impli-
cated (Berg and Geschwind, 2012; Geschwind and Levitt, 2007).
Analysis of copy number variation (CNV) and exome sequencing
have identified rare variants that alter dozens of protein-coding1008 Cell 155, 1008–1021, November 21, 2013 ª2013 Elsevier Inc.genes in ASD, none of which account for more than 1% of
ASD cases (Devlin and Scherer, 2012). This and the fact that a
significant fraction (40%–60%) of ASD is explained by common
variation (Klei et al., 2012) point to a heterogeneous genetic
architecture.
These findings raise several issues. Based on the background
human mutation rate (MacArthur et al., 2012), most genes
affected by only one observed rare variant to date are likely false
positives that do not increase risk for ASD (Gratten et al., 2013). It
is therefore essential to develop approaches that prioritize
singleton variants, especially missense mutations. Furthermore,
given the heterogeneity of ASD, it would be valuable to identify
common pathways, cell types, or circuits disrupted within ASD
itself. Recent studies combining gene expression, protein-
protein interactions (PPIs), and other systematic gene annotation
resources suggest some molecular convergence in subsets of
ASD risk genes (Ben-David and Shifman, 2013; Gilman et al.,
2011; Sakai et al., 2011; Voineagu et al., 2011). Yet, it remains
unclear how the large number of genes implicated through
different methods may converge to affect human brain develop-
ment, which is critical to a mechanistic understanding of ASD
(Berg andGeschwind, 2012). Additionally, ASD has considerable
overlapwith ID at the genetic level, so identifyingmolecular path-
ways and circuits that confer the phenotypic specificity of ASD
would be of considerable utility (Geschwind, 2011; Matson and
Shoemaker, 2009).
Here, we took a stepwise approach to determine whether
genes implicated in ASD affect convergent pathways during
in vivo human neural development and whether they are en-
riched in specific cells or circuits (Figure 1A). First, we con-
structed transcriptional networks representing genome-wide
functional relationships during fetal and early postnatal brain
development and mapped genes from multiple ASD and ID
resources to these networks. We then assessed shared neurobi-
ological function among these genes, including coregulatory
relationships and enrichment in layer-specific patterns from
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Figure 1. Methodological Overview and Coexpression Network Analysis
(A) Flowchart of the overall approach.
(B) Network analysis dendrogram showing modules based on the coexpression topological overlap of genes throughout development. Color bars below give
information on module membership, gene biotype, cortical region specificity, age trajectory, and robustness of module assignment.
(C) Module characterization, including GO enrichment and trajectory throughout development. The fit line represents locally weighted scatterplot smoothing
(Extended Experimental Procedures). GO enrichments are adjusted for multiple comparisons (FDR < 0.05), and reported Z scores represent relative enrichment in
the module compared to all cortex-expressed genes, with the red line at Z = 2.
See also Table S1 and Figure S1.microdissected human fetal and adult primate cortical laminae.
We used validation in independent in vivo and in vitro expression
data and additional functional evidence (shared annotated path-
ways and PPIs) to confirm shared coexpression and function
among genes, and we replicated the enrichment analyses in in-
dependent data to ensure robustness. Our integration of an un-Csupervised network analysis with large gene sets from multiple
resources permits rigorous interrogation of biological conver-
gence in ASD that takes its heterogeneity into consideration
and enables comparison of ASD with ID. In addition, we have
made these data accessible for biologists by creating an interac-
tive network web browser (Experimental Procedures).ell 155, 1008–1021, November 21, 2013 ª2013 Elsevier Inc. 1009
RESULTS
Genome-wide Coexpression Networks Reflect
Biological Processes Essential to Human Neocortical
Development
We reasoned that transcriptomic data from human neocortex
would inform our understanding of ASD pathophysiology, as
the cerebral cortex has been consistently implicated in ASD
pathophysiology by multiple modalities (Amaral et al., 2008;
Ecker et al., 2012; Geschwind, 2011; Rubenstein, 2011; Voi-
neagu et al., 2011). We focused on gene expression from cortical
development spanning postconception week (PCW) 8 to month
12 after birth, as this time period reflects many critical molecular
processes that orchestrate brain circuit formation that could be
disrupted by genetic hits in ASD (Andersen, 2003; Courchesne
et al., 2011).
We constructed networks of gene relationships agnostic to
ASD candidate genes based on BrainSpan whole-genome tran-
scriptomic data collected by RNA-seq (BrainSpan, 2013). We
applied signed weighted gene coexpression network analysis
(WGCNA; Experimental Procedures; Zhang and Horvath, 2005)
and identified 17 coexpression modules (labeled numerically,
e.g., M8, and by color, e.g., magenta, see Table S1B [available
online] for module details). These modules represent genes
that share highly similar expression patterns during cortical
development (Figure 1B). Several additional analyses show
that these modules identify highly significant shared expression
patterns that are replicated in independent data from both in vivo
and in vitro human neural development (Figures S1A–S1C and
Extended Experimental Procedures).
First, we investigated eachmodule’s developmental trajectory
by calculating the module eigengene (ME, the first principal
component of themodule) and assessed shared function among
genes within the module by enrichment for Gene Ontology (GO)
annotation terms. Representative examples for up- and downre-
gulatedmodules are shown in Figure 1C. MEs for M13, M16, and
M17 increase during early cortical development and are each
enriched for the GO term synaptic transmission (Figure 1C).
M16 is upregulated the earliest, starting at PCW 10 and its
hubs (most interconnected genes based on correlation to the
ME, kME) include genes coding for the structural synaptic pro-
teins SV2A and NRXN1. M16 GO terms include cation trans-
porter activity, homophilic cell adhesion, and nervous system
development, which is consistent with early development of
synaptic ultrastructure. M17 represents a later phase of synaptic
maturation, as it is upregulated after PCW 13, and its hubs
include CAMK2B and CACNA1C, which are important for cal-
cium-dependent regulation of synaptic activity. M13 increases
last, after PCW 16, and its hubs include the NMDA and GABA
receptor subunits GRIN2A and GABRA1, whereas GO terms
include substrate-specific channel activity and regulation of
neuronal synaptic plasticity. These three modules have closely
aligned but distinct developmental trajectories that likely reflect
sequential phases of synaptic development, maturation, and
function, all of which are essential to the development of the ce-
rebral cortex.
In contrast, M2 and M3 have anticorrelated trajectories to
M13, M16, and M17 (r = 0.46 to 0.96; Table S1B) and are1010 Cell 155, 1008–1021, November 21, 2013 ª2013 Elsevier Inc.enriched in GO terms associated with DNA binding and tran-
scriptional regulation (Figure 1C). Expression in M3 is initially
upregulated and then decreases after PCW 12, suggesting that
its functions may be most important prior to M2, which is upre-
gulated after PCW 10 and peaks later (PCW 12 to PCW 22).
Given the GO enrichment and anticorrelation to the synaptic
module MEs, genes in these modules may be critical to orches-
trating processes such as progenitor proliferation and cell fate
specification via initial repression followed by derepression of
neuronal genes (Srinivasan et al., 2012). Furthermore, many of
the genes found in M2 andM3 are part of well-studied chromatin
remodeling complexes, most notably the BAF complex (ARID1A
and SMARCA4 in M2; ARID1B, SMARCB1, SMARCC1,
SMARCC2, SMARCD1, ARID2, DPF2, BCL11A, BCL11B, and
ACTL6A in M3), which has recently been linked to neural differ-
entiation and neurodevelopmental disorders (Ronan et al.,
2013; Yoo et al., 2009).
Because positive correlations among genes also reflect pair-
wise interactions between proteins (Ramani et al., 2008), enrich-
ment for protein-protein interactions within modules provides an
independent line of validation for shared function in these mod-
ules at the protein level. We combined all known PPIs from
InWeb (Rossin et al., 2011) and BioGRID (Stark et al., 2006)
into one network, comprising 251,881 interactions among
18,384 proteins, and observed that 12/17 of all coexpression
modules, including all the modules in Figure 1C, are enriched
for PPI after stringent multiple testing correction (p < 0.003, Table
S1B). Overall, 10/17 coexpression modules are preserved in in-
dependent gene expression data sets, enriched for GO terms,
and enriched for PPI. An additional 2/17 modules are enriched
for two of these three criteria. These results demonstrate the util-
ity of a systems biology approach—instead of analyzing lists of
thousands of genes regulated during development, we focused
on this set of 12 reproducible and biologically meaningful
modules sharing distinct expression patterns and biological
functions. An interactive network is available at our website for
graphical exploration of individual genes in these modules, as
well as their relationships with each other (Experimental
Procedures).
Genes Implicated in ASDAre Highly Coexpressed during
Human Cortical Development
We next asked whether genes associated with risk for ASD
converge on common biological processes. We compiled a set
of 155 ASD genetic risk candidates from the Simons Foundation
Autism Research Initiative (SFARI) AutDB database (Basu et al.,
2009), which we refer to as SFARI ASD. The SFARI ASD list is a
manually curated set of candidate genes implicated by common
variant association, candidate gene studies, genes within ASD-
associated CNV, and, to a lesser extent, syndromic forms of
ASD (Experimental Procedures). We mapped this gene set to
the protein-coding genes in the developmental coexpression
network and observed that SFARI ASD genes are most overrep-
resented in M16 (p = 0.0024; odds ratio [OR] = 2.9; 95% confi-
dence interval = [1.4–5.5]; false discovery rate [FDR] < 0.05)
and less so in M13 and M17 (Figure 2A).
We also examined a set of ASD genes previously shown to be
dysregulated in postmortem ASD temporal and frontal cortex
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Figure 2. Enrichment of SFARI ASD,
asdM12, and ID Genes in Developmental
Networks
(A) Module-level enrichment for gene sets from a
curated set of ASD risk genes (SFARI ASD), a
curated set of ID genes (‘‘ID all’’), and an unbiased
set of ASD risk genes (asdM12). Overlapping
(ASD/ID overlap) and nonoverlapping sets (‘‘ASD
only’’ and ‘‘ID only’’) are also shown. All enrichment
values for overrepresented lists with p < 0.05, OR >
1 are shown to demonstrate enrichment trends
(*p < 0.05 and **FDR < 0.05). Heatmap colors for p
values reflect enrichment trends; p values for gene
sets with OR < 1 can be seen in Table S2B.
(B–D) These panels show network plots for M13,
M16, and M17, respectively. Most hub genes
overlapping with SFARI ASD and asdM12
enrichment are not the same, showing that
enrichment of these two sets is not driven by a
narrow shared subset of genes. Network plots
comprise the top 200 connected genes (based
on kME, a measure of intramodular connectivity)
and their top 1,000 connections in the subnet-
work. By definition, all edges in the network
reflect positive correlations. Genes with mem-
bership in SFARI ASD, asdM12, or the ‘‘ID all’’
list are labeled and plotted according to multi-
dimensional scaling of gene expression correla-
tions, which graph genes with similar expression
patterns closer to each other.
See also Table S2.
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(asdM12; Voineagu et al., 2011), which represents a shared
molecular pathology in ASD brain identified in an unbiased,
genome-wide manner. The asdM12 gene set was strongly
enriched in the same three modules as SFARI ASD genes,
M13, M16, and M17 (asdM12-M13; p = 3.0 3 1015; OR 3.6
[2.7–4.8]; asdM12-M16; p = 3.5 3 1015; OR 3.9 [2.8–5.3];
asdM12-M17; p = 1.0 3 107; OR 2.5 [1.8–3.4]; each at FDR <
0.05). A remarkable 42% of asdM12 and 25% of the SFARI
ASD sets are found in one of these three modules. Our analysis,
which uses gene sets identified based on different methods (only
15 genes overlap between SFARI ASD and asdM12), converges
onto three modules involved in prenatal and early postnatal syn-
aptic development.
We next hypothesized that mapping ID genes to this network
would enable us to assess whether ASD susceptibility genes
show any specificity in their developmental expression patterns.
We compiled an extensive set of high confidence genes impli-
cated in monogenic forms of ID frommultiple publications (Inlow
and Restifo, 2004; Lubs et al., 2012; Ropers, 2008; van Bok-
hoven, 2011), referred to as ‘‘ID all’’ (see Experimental Proce-
dures). Remarkably, this set of 401 genes (of which 364 are
expressed in human neocortex) is not enriched in any of the 12
coexpression modules. Importantly, this lack of enrichment is
at a relaxed threshold that reduces the risk of false negatives (un-
corrected p > 0.05). Removing the small set of 37 genes (<10%)
that overlap between ASD and ID to establish exclusive sets
(‘‘ASD only’’ and ‘‘ID only’’) further confirms that ASD genes
exhibit enrichment, whereas ID genes do not (Figure 2A and Ta-
ble S2B). Thus, it is genes connected with the ASD phenotype
that are enriched in three specific transcriptional modules related
to synaptic function during development, but not those that have
been related solely to ID.
Rare De Novo Variants Are Highly Enriched in Two
Coexpression Modules in Early Fetal Development
Additional evidence implicating specific genes in ASD comes
from whole-exome sequencing in families (Iossifov et al., 2012;
Neale et al., 2012; O’Roak et al., 2012b; Sanders et al., 2012),
which has identified many rare protein-disrupting variants
(nonsense, splice site, and frameshift) overrepresented in in-
dividuals with ASD compared to their unaffected siblings
(OR > 2). This evidence is largely distinct from the evidence impli-
cating genes in SFARI ASD and asdM12, as it is from purely
noninherited, rare variation discovered in an unbiased,
genome-wide manner. We therefore asked whether genes
affected by protein altering rare de novo variation (RDNV) in
ASD probands shared biological function. We also tested silent
RDNVs because they should not exhibit a similar pattern of func-
tional enrichment, providing a key control for gene size, GC con-
tent, and other features affecting mutability (Michaelson et al.,
2012).
We first tested for enrichment using RDNVs from three studies
sharing similar coverage criteria and variant calling methodology
(Neale et al., 2012; O’Roak et al., 2012b; Sanders et al., 2012),
representing 622 ASD probands and 222 unaffected siblings.
Strikingly, genes expressed during development and affected
by protein-disrupting RDNVs in probands (60 genes, Table
S2A, Discovery Set) are significantly enriched in two modules,1012 Cell 155, 1008–1021, November 21, 2013 ª2013 Elsevier Inc.M2 and M3, which exhibit highly similar developmental trajec-
tories and functional enrichment indicative of remarkable biolog-
ical specificity. Eight genes harboring protein-disrupting RDNVs
are enriched in M2 (p = 0.006; OR = 3.2 [1.3–6.8]; FDR < 0.05),
and ten are enriched in M3 (p = 0.0011; OR = 3.6 [1.6–7.2];
FDR < 0.05). A trend for enrichment is observed for M16 as
well, but this does not pass the FDR threshold. For comparison,
genes affected by RDNVs in unaffected siblings or affected by
silent mutations are not enriched in any modules (Table S2B, p
> 0.05). Because missense RDNVs are only weakly overrepre-
sented in ASD (Sanders et al., 2012), we reasoned that overlap
with network modules might prioritize specific subsets of this
RDNV class. We find that a subset of missense RDNV affected
genes is overrepresented in the same pathways as the more
deleterious protein-disrupting RDNVs (M2 and M3; Table S2B).
Taken together, out of 385 protein-disrupting or missense
RDNV-affected genes expressed in brain, 34 are found in M2
(p = 2.9 3 104; OR = 2.1 [1.4–3.0]; FDR < 0.05) and 41 in M3
(p = 2.3 3 105; OR = 2.2 [1.5–3.1]; FDR < 0.05). Furthermore,
the combined set of protein-disrupting and missense RDNVs
from unaffected siblings was not found enriched in any modules
(p > 0.05).
We further validated the observed RDNV enrichment pattern in
M2 and M3 in an independent set of patients from a study with
more stringent RDNV calling criteria (Iossifov et al., 2012). In
this additional set of 343 ASD probands and unaffected siblings,
we found that the patterns of RDNV enrichment replicated, with
the combined protein-disrupting and missense RDNV sets from
ASD probands enriched specifically in M2 and M3 (p < 0.05) and
RDNVs from siblings and silent RDNVs not enriched in any set
(Table S2B; Replication Set). Combining all four studies, we
find that, out of 598 protein-disrupting or missense RDNV-
affected genes expressed in cortex, 52 are in M2 (p = 9.6 3
106; OR = 2.0 [1.5–2.8]), and 61 are in M3 (p = 8.5 3 107;
OR = 2.1 [1.6–2.8]). Importantly, the enrichment pattern across
modules is not only replicated in the independent set but is stron-
ger in the combined set, is robust to perturbations in module
composition (Figure S3A), and is not driven by variants from
any one study (Tables S2C and S2D). We show the enrichment
pattern of this combined set across 965 ASD probands and
565 unaffected siblings in Figure 3A and use this combined set
for the remainder of our analyses. Furthermore, modules
showing weak enrichment in some mutation categories of the
discovery set (M11, M16 at p < 0.05, but not FDR < 0.05) did
not replicate at p < 0.05 in the replication set and are not enriched
when considering all four studies together (Figure 3A).
We next asked whether M2 and M3 prioritized functional sub-
sets of genes with RDNVs. We confirmed that RDNV-affected
genes in M2 and M3 are significantly enriched for interactions
at a protein level (Figures S2A–S2D) and highlight genes that
are both PPI hubs and coexpression hubs in Figures 3B and
S3C. Furthermore, M2 and M3 genes harboring protein disrupt-
ing or missense RDNVs are also more dosage sensitive, as evi-
denced by the significant increase in the probability of haploin-
sufficiency (P[HI], Extended Experimental Procedures) among
genes affected by these mutation classes (Huang et al., 2010;
Luo et al., 2012). This is consistent with the heterozygous state
of variants observed in ASD probands. Overall, a remarkable
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Figure 3. Enrichment of Genes Affected by
RDNVs in Developmental Networks
(A) Module-level enrichment for multiple cate-
gories of RDNV in ASD affected probands and
unaffected siblings combined across four studies.
M2 and M3 are strongly enriched for protein dis-
rupting and missense RDNV-affected genes in
probands. Enrichment for genes affected by silent
RDNVs in probands and RDNV gene sets affected
in siblings represent control gene sets and do not
show enrichment. All enrichment values for over-
represented lists with p < 0.05, OR > 1 are shown
to demonstrate enrichment trends (*p < 0.05,
**validated in replication set). Heatmap colors for
p values reflect enrichment trends; p values for
gene sets with OR < 1 can be seen in Table S2B.
(B and C) (B) and (C) show network plots for M2
and M3, with all genes plotted and all genes car-
rying RDNVs displayed.
Network plots show all genes in the module with
protein disrupting or missense RDNV-affected
genes highlighted. For visualization, genes with
high intramodular connectivity (kME > 0.75) are
labeled in black, and the rest are labeled in gray. By
definition, all edges in the network reflect positive
correlations. The top 1,000 connections are
shown, and genes are plotted according to the
multidimensional scaling of coexpression as in
Figure 2. See also Figures S2 and S3 and Table S2.
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proportion (113/598 [19%]) of genes affected by known RDNVs
are coexpressed in two modules reflecting similar temporal
trends of high expression in cortex during the neurodevelopmen-
tal period of early neuronal fate determination, migration, and
cortical lamination. Of note, as with M13, M16, and M17, which
were enriched for asdM12 and SFARI ASD, ID genes did not
show enrichment in M2 or M3 (p > 0.05).
We also observed that the SFARI ASD genes and asdM12
genes, which are enriched for inherited common variants in
ASD (small average effect size), affect the synaptic modules,
M13,M16, andM17. In contrast, the noninherited (larger average
effect size) RDNVs preferentially affect the early transcriptional
regulation modules (Extended Experimental Procedures). We
emphasize that this is not absolute, asM16 includes some genes
harboring RDNVs (e.g., in SCN2A, SHANK2, and NRXN1; Fig-
ure 2A). To formally assess common variant enrichment using
independent data, we compared ASDGWA signals across these
modules (Extended Experimental Procedures). Genes in M13
and M16 were more strongly affected by common variation
than M2 or M3 in at least one of two ASD GWA studies (Anney
et al., 2012; Wang et al., 2009) (Figure S3E). This is consistent
with susceptibility of distinct biological processes for different
mutational classes. In general, we predict that more severe neu-
rodevelopmental consequences would result from disrupting
early transcriptional dysregulation during neuronal proliferation
and differentiation, as compared with later disruption of synaptic
development and neuronal function.
ASD Gene-Enriched Modules Are Linked by
Translational and Transcriptional Regulation
Upregulated and downregulated modules are highly anticorre-
lated throughout development, so we hypothesized that com-
mon molecular regulatory relationships could potentially link
genes within these modules. We first used a set of FMRP-RNA
interactors from a crosslinking and immunoprecipitation (CLIP)
experiment (Darnell et al., 2011) because Iossifov et al. (2012)
had previously shown that RDNVs identified in their exome
sequencing study were enriched in this class of genes. Remark-
ably, FMRP targets are specifically enriched in modules that also
contain ASD-related genes M2, M16, and M17 (FMRP-M2 p =
1.6 3 1013; OR = 3.0 [2.3–3.9]; FMRP-M16 p = 2.4 3 1029;
OR = 5.7 [4.3–7.6]; FMRP-M17 p = 9.3 3 1010l OR = 2.4
[1.8–3.1]; all at FDR < 0.05; Figure 4A). This provides a strong,
independent line of evidence that translational regulation by
FMRP not only affects genes harboring RDNVs but also links
different molecular pathways that are coexpressed during early
fetal cortical development and are susceptible to diverse classes
of ASD genetic mutation.
We next tested whether ASD-associated modules are also
linked at the transcriptional level (Experimental Procedures).
We found 17 TFs that are predicted to link at least one upregu-
lated and one downregulated module based on binding site
enrichment (Figure 4B and Tables S3A and S3B). Many of the
genes encoding these TFs are expressed during fetal develop-
ment (Table S1A), have been previously implicated in relevant
neuronal functions, and have DNA binding targets that have
been experimentally characterized (Table S3B). For example,
MEF2A andMEF2C, bothmembers of a TF family regulating syn-1014 Cell 155, 1008–1021, November 21, 2013 ª2013 Elsevier Inc.aptic plasticity and glutamatergic synapse number (Ebert and
Greenberg, 2013), are enriched for binding targets in M2 and
M17, which are anticorrelated across development (Figures 4C
and 4D). SATB1, which is required for the development of
cortical interneurons (Close et al., 2012), ELF1, which is involved
in axonal guidance, and FOXO1, which regulates neuronal polar-
ity (de la Torre-Ubieta and Bonni, 2011) also link these two mod-
ules (Figures 4E and 4F). To provide further evidence that these
are experimentally plausible binding sites, we overlaid TF gene
bioinformatic predictions with chromatin immunoprecipitation
(ChIP) data where available, supporting many of these predicted
interactions, including 39% of MEF2A, 23% of MEF2C, and 87%
of ELF1 interactions (Figure 4C, 4D, and 4G and Extended
Experimental Procedures). These results implicate existing and
novel TFs as putative coregulators of ASD-associated gene
networks during neocortical development.
ASD-Associated Genes Exhibit Laminar and Cellular
Enrichment
Deficits in cortical patterning have been observed in ASD
(Voineagu et al., 2011), so we tested whether ASD-affected
genes are enriched in the developing laminae of fetal cortex
and the terminally differentiated laminae of adult cortex (Experi-
mental Procedures). We compared multiple ASD gene lists with
the ID gene sets for enrichment in laminae of the developing and
adult cortex and found a sharp contrast in laminar enrichment
between ASD and ID genes (Figures 5A and 5B). Additionally,
in adult, asdM12 exhibits strongly significant enrichment in L3
(Z > 2.7, FDR < 0.01), whereas other ASD lists follow a similar
trend of superficial layer enrichment (Z > 2, p < 0.05). In contrast,
the ‘‘ID all’’ and ‘‘ID only’’ gene sets follow a trend of lower layer
enrichment (Figure 5B), an across-layer pattern that is signifi-
cantly different from all of the ASD lists (Figures 5C and 5D and
Extended Experimental Procedures).
We also observed a similar trend in superficial layer (L2–L4)
enrichment for the modules that are enriched in asdM12 genes
(M13, M16, and M17; Figure 5F). M13 and M16 also exhibit
weaker enrichment in deeper layers (L5 and L6). Module-level
analysis in fetal brain also highlighted a difference between the
RDNV-enriched modules, M2 and M3. Although both M2 and
M3 are most highly expressed in early human fetal development
(prior to PCW17), M2 reaches its peak later and is enriched in the
cortical plate (CPi/CPo), whereas M3 peaks earlier, which is
consistent with its enrichment in the germinal zone (VZ, SZi,
and SZo; Figure 5E). In adult, this distinction is no longer present
(Figure 5F), with both M2 and M3 showing enrichment in super-
ficial layers (L2 and L4). We also asked whether any of these
gene sets or modules were enriched for cell-type-specific
marker expression patterns paralleling the observed laminar
enrichment. We observed enrichment for a set of well-curated
upper-layer glutamatergic neuron markers among asdM12,
M2, and M3 genes (Extended Experimental Procedures and Fig-
ures S4C and S4D), which agrees with the L2-4 enrichment of
asdM12 and ASD risk gene modules.
Figure 6A highlights adult layer-level expression patterns of
several strong ASD candidate genes with enriched expression
in superficial layers (e.g., SHANK2 and CNTNAP2) and shows
that many genes recurrently affected by protein-disrupting
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Figure 4. Translational and Transcriptional
Coregulation Connect Developmentally
Distinct ASD-Affected Modules
(A) Coexpression-based network plot of FMRP
interactions with genes in M2, M16, and M17 that
are either affected by RDNVs or are in an ASD
candidate list. Genes are plotted as in Figures 2
and 3 but now across modules, with FMRP placed
at the center.
(B) Summary of TF binding site (TFBS) enrichment
in modules for TFs that have evidence for function
in a neurodevelopmental context and link anti-
correlated modules. Dashed lines indicate enrich-
ment in the module for predicted binding sites.
(C–G) MEF2A, MEF2C, SATB1, FOXO1, and ELF1
are all enriched for their binding motifs in the up-
stream regions of ASD gene-enriched modules
following anticorrelated developmental patterns.
Network plots highlight genes with a predicted
binding site (light dashed arrow) for the TF (placed
at the center) contributing to this enrichment that
are also affected by RDNVs or in an ASD candi-
date list. Arrows representing a TFBS found in a
ChIP experiment are marked in dark blue.
For network plots, the top 1,000 positive con-
nections between genes are plotted, and node
size is proportional to connectivity within the
genes’ assigned module; therefore, larger nodes
are more central hubs. The outer color of each
node reflects its module membership, and coex-
pression edges in the network reflect positive
correlations. See also Tables S2 and S3.RDNVs in the 965 ASD probands and an additional set of pa-
tients assessed by targeted sequencing (O’Roak et al., 2012a)
also show superficial layer enrichment (e.g., SCN2A andCell 155, 1008–1021, NoPOGZ; Figure 6B). We use these laminae
for cell-marker enrichment analyses
because adult laminar expression pat-
terns are more clearly delineated relative
to PCW 15–21 (Figures 5A, 5E, S4A, and
S4B). Furthermore, neuronal migration in
humans persists into the third trimester,
and upper-layer neuronal identity is not
finalized until after PCW 28 (Bystron
et al., 2008). Out of the six genes with
recurrent RDNVs in probands in which
we can detect layer preference, five are
predominantly expressed in superficial
layers in adult. Some of the genes in Fig-
ure 6 also show expression in a lower
layer (NLGN1, SCN2A, ITPR1, and
MLL3), though superficial layer enrich-
ment is stronger (larger differential
expression t value in Table S1A).
DISCUSSION
Our analyses offer a genome-wide neuro-
biological context to begin to unify the ge-netics of ASD, providing robust evidence of both molecular
pathway and circuit-level convergence (Figures 7A and 7B). Inte-
gration of ASD genes with developmental coexpressionvember 21, 2013 ª2013 Elsevier Inc. 1015
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A B Figure 5. Enrichment for Laminar Differen-
tial Expression of Gene Sets and Associated
Developmental Coexpression Modules in
Fetal Human and Adult Primate Cortex
(A) In fetal cortex, ASD sets (SFARI, asdM12, and
RDNV affected) are enriched for differential
expression in laminae containing postmitotic
neurons, whereas genes implicated in ID are
weakly enriched in germinal layers. A high Z score
for a gene set in a layer corresponds to differential
expression across the gene set in that layer.
(B) In adult cortex, asdM12 sets show strong
enrichment in layer 3, whereas ID genes are
weakly enriched in layer 5.
(C and D) Summing the Z score across layers in (A)
and (B) and comparing to randomly permuted sets
of genes of similar size demonstrates that, in both
fetal and adult cortex, the laminar distribution of
multiple ASD implicated gene sets is significantly
distinct from that of genes implicated only in ID.
(E) SFARI/asdM12-associated developmental
coexpression modules M13, M16, and M17 follow
enrichment trends similar to the SFARI/asdM12
gene set in fetal brain. However, the modules
strongly associated with the RDNV affected
genes, M2 and M3, show distinct enrichment
patterns.
(F) ASD-associated modules are predominantly
enriched in superficial layers 2–4 of adult cortex.
Additionally, M16 shows weak enrichment in L5.
In contrast to fetal cortex, M2 and M3 are in en-
riched in the same laminae in adult, suggesting
that they serve distinct functions during cortical
development that contribute to superficial cortical
layers 2–4.
Dashed lines in bar plots indicate Z = 2.7 (equiv-
alent to FDR = 0.01); error bars indicate 95%
bootstrapped CIs. Laminae: marginal zone (MZ),
outer/inner cortical plate (CPo/CPi), subplate (SP),
intermediate zone (IZ), outer/inner subventricular
zone (SZo/SZi), ventricular zone (VZ), and adult
cortical layers 2–6 (L2–6). See also Figure S4.networks and laminar expression data connects multiple ASD
risk-enrichedmodules to glutamatergic neurons in upper cortical
layers, tying ASD risk genes to specific brain circuitry (Figure 7C).
The observation of convergent biology in ASD stands in striking
contrast with ID, which does not show the same level of develop-
mental or anatomical specificity. Laminar enrichment in the
‘‘ASD/ID overlap’’ genes shows a similar pattern as the ‘‘ASD
only’’ genes (in L2, Figure 5B). Therefore, disruption in ID genes
that also cause ASD affects superficial layers compared to
disruption in genes causing ID only. Our analyses lead to the pre-
diction that specific disruption of cortical-cortical connectivity—
by targeting upper layer glutamatergic neurons that predomi-
nantly comprise inter- and intrahemispheric projections, for
example—is more likely to affect core ASD phenotypes such
as social behavior, rather than general intellectual ability alone.
Our analysis further links specific molecules and pathways
to the cortical-cortical intra- and interhemispheric disconnection
that has been hypothesized as a shared circuit-level deficit
unifying diverse ASD etiologies (Belmonte et al., 2004; Gesch-
wind and Levitt, 2007). An illustrative example is the disruption1016 Cell 155, 1008–1021, November 21, 2013 ª2013 Elsevier Inc.of ARID1B, a BAF complex member that harbors a RDNV
and is a hub of M3. Severe mutations in ARID1B cause corpus
callosum abnormalities, ID, and ASD (Halgren et al., 2012;
Santen et al., 2012). Another BAF complex member, SMARCC2,
implicated by RDNVs in probands, controls cortical thickness
by repressing the pool of intermediate progenitors, which prefer-
entially contribute to forming cortical layers 2–4 (Tuoc et al.,
2013), providing another molecular link to inter- and intrahemi-
spheric connectivity. These analyses make the first systematic
connection between genes disrupted in ASD and this circuit-
level disruption. As additional genes in the early fetal coex-
pression modules are found to harbor recurrent RDNVs,
cortical-cortical connectivity will be a valuable phenotype to
assess in both animal models and human patients.
Translational regulation by FMRPduring fetal cortical develop-
ment and transcriptional coregulation of ASD candidate genes
provide another level of convergent biology in ASD and a rich
starting point for further experimental investigation. Notable
also are TFs that are predicted to drive the transcriptional core-
gulation of molecular and circuit-level processes, including
SFARI ASD candidate genes
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Figure 6. Laminar Patterns for Genes Impli-
cated in ASD
(A) SFARI candidate genes for ASD.
(B) Genes with recurrent RDNV evidence across
studies. Genes not displayed include TBR1 (lower
layer enriched), CHD8 (no layer enrichment de-
tected), CUL3 (no layer enrichment detected), and
KATNAL2 (not detected in these data).
(C) Genes with high connectivity in M13, M16,
and M17.
(D) RDNV genes with high connectivity in M2
and M3.
aindicates membership in SFARI ASD, b indicates
membership in asdM12, c indicates the gene is
affected by a RDNV, and the asterisk indicates
recurrent RDNVs.
Color bar values represent scaled expression (SDs
from the mean-centered expression value across
layers). All genes shown have t > 2 for enrichment
in an upper layer (L2, L3, or L4) over background
and t < 2 for lower layers (L5 or L6). Regions:
dorsolateral prefrontal (DLPFC), orbitofrontal
(OFC), anterior central gyrus (ACG), primary motor
(M1), primary somatosensory (S1), primary audi-
tory (A1), higher-order visual area TE (TE), higher-
order visual area MT/5 (MT), secondary visual
cortex (V2), and primary visual cortex (V1).MEF2A, MEF2C, and SATB1, which have binding site enrich-
ment in M2 and M17. This is intriguing in light of decreased
PVALB expression in ASD brain (Voineagu et al., 2011), the hy-
pothesized convergent mechanism of a shift in the excitation-in-
hibition balance in ASD (Rubenstein and Merzenich, 2003), and
the observation that SATB1 plays a key role in regulating cortical
PV+ and SST+ interneuron development (Close et al., 2012; De-
naxa et al., 2012). We speculate that M2 and M17 reflect pro-
cesses involved in the migration and differentiation of inhibitory
and excitatory cell populations whose balanced coregulation
may be essential to proper cortical development. These ana-
lyses underscore the notion that understanding the structure of
the transcriptional and chromatin regulatory networks underlying
cortical development and their relationship to translational con-
trol will better inform the genetic risk architecture of ASD.Cell 155, 1008–1021, NoIn addition to demonstrating biological
convergence, network analysis further al-
lowed us to stratify the full set of 684
RDNV-affected genes to a narrower list
of 113 genes (Table S1A) that we hypoth-
esize are more likely to confer increased
ASD risk based on their enrichment in
M2 and M3 and an elevated probability
of conferring a phenotype when haploin-
sufficient. Furthermore, we demonstrate
that the observed enrichment is specific
by comparison to silent RDNVs and unaf-
fected siblings’ RDNVs. As an example of
how to prioritize these candidates further
based on the functional relationships
summarized in Figure 7, we constructeda list of candidates using Table S1A, filtering by expression dur-
ing development, membership in M2 or M3, high predicted hap-
loinsufficiency (P[HI] > 0.5), protein disrupting or missensemuta-
tion in probands, and either a layer preference (t > 2 for a
particular layer) or a cell-type preference (r > 0.2 for a cell type)
in Table S4. This yields a set of 24 candidates with a hypothe-
sized layer or cell-type phenotype for investigation. Among
these, TBR1 is known to harbor recurrent mutations, whereas
CHD3 is a member of the same gene family as CHD8, a gene
with strong recurrent de novo mutation evidence (O’Roak
et al., 2012a). Additionally, SMARCC1 and SMARCC2 are mem-
bers of the BAF complex, which is of particular interest because
it is statistically associated with ASD—6/28 BAF complex genes
are affected by RDNVs (p = 0.0015; OR = 5.7 [1.9–14.5]).
Remarkably, one of the genes in M2 implicated by ourvember 21, 2013 ª2013 Elsevier Inc. 1017
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Figure 7. Summary of Findings and Model
for Effects of ASD Implicated Gene Sets
(A) ASD risk genes from multiple sources were
enriched in five coexpression modules throughout
development—M2, M3, M13, M16, and M17.
(B) Early transcriptional regulators in M2/M3 are
enriched for RDNVs, whereas the later expressed
synaptic genes are associated with previously
studied ASD genes (biological process time pe-
riods adopted from Andersen [2003]).
(C) ASD genes are most consistently associated
with laminae containing postmitotic neurons dur-
ing early fetal development (broadly in IZ, SP, CPo/
CPi, andMZ) and superficial layers in adult (L2–L4).
Multiple modules are also strongly associated with
markers of upper-layer glutamatergic neurons in
adult cortex, suggesting many ASD genes prefer-
entially affect these cell types.
(B) and (C) also summarize that ID genes are largely
distinct from ASD genes in both developmental
trajectory and neocortical layer enrichment.
See also Table S4. Both (A) and (B) correspond to
the same timescale as marked by the axis on the
plot in (A). We summarize the strongly enriched
findings but note that weaker enrichment for other
patterns exists that may be important for subsets
of ASD. Individual genes can be prioritized for
biological validation using a combination of
network position, bioinformatic scores, and the
biological context highlighted here, as described in
the Discussion and as shown in Table S4.prioritization is TOP1 (also highlighted in Figures 3B, and S2A,
and S2B), as it contains a missense RDNV, has a P(HI) of 0.99,
and is correlated with upper-layer glutamatergic neuronal
markers. TOP1 has been shown to regulate the transcrip-
tion of long transcripts preferentially implicated in ASD (King
et al., 2013). Therefore, M2 provides many potential
interactions to investigate at a mechanistic level, as it links
TOP1 with other regulators of chromatin structure expressed
during cortical development that include members of CCR4-
NOT complex (CNOT family) and chromodomain helicase
DNA-binding proteins (CHD), which have previously been linked
to the regulation of neuronal proliferation and differentiation
(Feng et al., 2013; Potts et al., 2011; Ronan et al., 2013; Zheng
et al., 2012).
In parallel work in this issue of Cell, Willsey et al. (2013) find
strongest convergence on fetal developmental coexpression
networks in frontal lobe by seeding with a subset of high-confi-
dence ASD genes identified by exome sequencing. Despite the
different analytical approaches, there is remarkable overlap be-
tween the developmental processes implicated by the gene net-
works identified in our studies. Although we see the strongest
cell type and layer enrichment in adult L2–L4, we also see a
signal in CPi during fetal development and a weaker signal in
L5–L6 of adult, which is consistent with a subset of genes
affecting lower-layer glutamatergic neurons. Together, our
studies highlight the importance of understanding the spatial
and temporal context of specific genes for future mechanistic
investigation.1018 Cell 155, 1008–1021, November 21, 2013 ª2013 Elsevier Inc.We also acknowledge several issues that challenged our
approach. Many of the genes we identified as putatively involved
in ASD do not have complete PPI data, P(HI) scores, TF binding
site information, or are not well studied in brain. This is one
reason why we rely most heavily on RNA-seq-based transcrip-
tome data, as they comprehensively represent relationships pre-
sent in the developing human brain in an unbiased manner. We
did not assess enrichment of genetic hits in other brain regions
across development, as sample size and cell-type heterogeneity
make it difficult to interpret coexpression across cytoarchitectur-
ally diverse brain regions such as cerebellum and amygdala,
which may also be involved in ASD (Amaral et al., 2008). We
also focused on single gene disruption in ASD and did not
include CNVs affectingmultiple genes to improve signal to noise.
Additionally, current genetic approaches favor de novo muta-
tion detection; as different classes of mutations (e.g., inherited
rare coding or noncoding regulatory variants) are identified, we
speculate that heritable variants will have less severe phenotypic
consequences and will affect genes in the modules related to
synaptic development and function, rather than earlier transcrip-
tional regulation. Likewise, it will also be useful to investigate
rare, inherited recessive ASD risk variants (Lim et al., 2013; Yu
et al., 2013) when sufficient data are available, so as to compare
it with other forms of genetic variation. Importantly, as larger sets
of individuals are sequenced, it will be essential to look at how
mutational effect relates to biological effect, as recent work (Yu
et al., 2013) has shown that ASD can result from milder hits to
the same proteins affected in more severe disorders associated
with severe ID. Here, we investigated a large composite list of
known ID genes that reflects multiple mutational mechanisms.
Certain subgroups of ID genes such as those implicated in
X-linked ID (Lubs et al., 2012) or those from de novo disruptions
in individuals with severe ID (de Ligt et al., 2012; Rauch et al.,
2012) overlap with genes in M2 and M3 that also have RDNVs
found in ASD. This is consistent with the observation that hits
in M2 and M3 are highly deleterious to brain development.
Although more specificity for these subgroups of ID genes may
arise as additional individuals are sequenced, our analyses indi-
cate that the degree of stage or regional specificity for ID genes is
far less than that observed in ASD.
The conclusions summarized in Figure 7 pass a stringent mul-
tiple comparisons cut-off; weaker enrichment patterns may
become more salient with higher-resolution tiling of gene
expression during development and increased sample sizes in
sequencing studies. To facilitate future studies, we have shared
the code used in this analysis (Extended Experimental Proce-
dures) and have provided a network browser for user-friendly
interactive exploration of specific genes, including links to other
public data (Experimental Procedures). We have shown how an
integrative approach, which is not driven by any small set of sam-
ples, candidate genes, or candidate hypotheses, can place het-
erogeneous genetic etiologies into a unifying structure. These
analyses provide aworking framework formechanistic investiga-
tion and hypothesis testing, which points to interactions between
genes in specific cell types and circuits, as well as the general
biological processes in which these genes are implicated.
EXPERIMENTAL PROCEDURES
Developmental Expression Data
BrainSpan developmental RNA-seq data (BrainSpan, 2013) summarized to
Gencode 10 (Harrow et al., 2006) gene-level reads per kilobasemillionmapped
reads (RPKM) values were used (Extended Experimental Procedures for data
preprocessing; see Table S1D for sample details). Only neocortical regions
were used in our analysis, and only genes with a normalized RPKM value of
1 in at least one region at one time point for 80% of the available samples
were considered expressed.
Weighted Gene Coexpression Network Analysis
We used the R package WGCNA (Langfelder et al., 2008) to construct coex-
pression networks, as previously done (Voineagu et al., 2011) and as
described in detail in the Extended Experimental Procedures. The modules
were characterized using GO Elite to control the network-wide FDR, with all
enriched pathways comprising at least ten genes at Z > 2 and FDR < 0.05
(Zambon et al., 2012). All network plots were constructed using the igraph
package in R (Csa´rdi and Nepusz, 2006).
Protein-Protein Interaction Enrichment
When assessing PPI enrichment in modules, a degree-matched permutation
analysis was applied in order to control for biological and methodological
biases in PPI data (see Extended Experimental Procedures for details).
Gene Sets
The SFARI ASD set was compiled using the online SFARI gene database,
AutDB.We used the ‘‘Gene Score,’’ which classifies evidence levels, to restrict
our set to those categorized as Syndromic (S) and evidence levels 1–4 (high-
confidence—minimal evidence). We obtained asdM12 and adsM16 from a
prior, independent gene expression study that profiled expression changes
in ASD cortex and applied WGCNA to identify modules of dysregulated genes
ASD (Voineagu et al., 2011). We curated ID genes from four reviews catalogingCgenes causing ‘‘ID all’’ (Inlow and Restifo, 2004; Lubs et al., 2012; Ropers,
2008; van Bokhoven, 2011) resulting in 401 genes. For candidate lists, we
used the HUGO gene nomenclature to find updated gene symbols. We
obtained RDNVs from four publications (Iossifov et al., 2012; Neale et al.,
2012; O’Roak et al., 2012b; Sanders et al., 2012) and split them into discovery
and validation sets as discussed in the results (see Extended Experimental
Procedures for further details about gene sets).
Gene Set Overrepresentation
All enrichments of gene sets were performed using a two-sided Fisher’s exact
test with 95% confidence calculated according to the R function fisher.test.
The FDR was controlled across candidate ASD gene set enrichments, the dis-
covery RDNV set enrichment, and FMRP target enrichment (Table S2B). For
RDNV enrichment, we required an OR > 1 and an FDR-adjusted p value <
0.05 for enrichment in the discovery set and OR > 1 with p < 0.05 for validation
in the replication set. When claiming a lack of enrichment, we require an uncor-
rected p > 0.05 to reduce false negatives, as future studies that add expression
time points for networks and genes for enrichment may find enrichment in
pathways not significantly enriched here.
Transcription Factor Binding Site Enrichment
The top 200 genes in each module (ranked by kME) were used for TF motif
enrichment analysis. Enrichment for each TF motif in TRANSFAC (Matys
et al., 2003) was compared to three background data sets to ensure robust-
ness: 1,000 bp sequences upstream of all human genes, human CpG islands,
and the sequence of human chromosome 20 (Extended Experimental Proce-
dures). Only TFs with p < 0.05 across all backgrounds are considered
enriched. ChIP data were obtained from ENCODE (ENCODE Project Con-
sortium, 2011) and the ChIP enrichment analysis (Lachmann et al., 2010)
resource.
Layer-Specific and Cell-Type Marker Enrichment
We utilized human fetal neocortical laminar gene expression data sets from
BrainSpan at PCW 15/16 and PCW 21 and primate neocortical laminar gene
expression data from a published study (Bernard et al., 2012). For laminar
specificity, differential expression of each gene in each layer was calculated
against background, resulting in t values for each gene in each layer (Table
S1A). We quantified the skew of differential expression t values of each gene
set in each layer, applied a FDR cutoff across all enrichments in all layers
(Z = 2.7 and FDR = 0.01), and computed bootstrapped confidence intervals
to assess enrichment of gene sets in layers. To quantify cell-marker relation-
ships, we used an analogous method, replacing the t value by the correlation
of each gene to the first principal component of a set of known cell marker
genes in the adult layer data (Table S1A). Statistical comparison of enrichment
trends across layers between ASD and ID gene sets set was performed by
comparing the distribution of scores across layers using a permutation anal-
ysis (Extended Experimental Procedures).
Interactive Network Plot
We have made the coexpression network and associated gene-level data
available for the top 500 connections in each module in an interactive browser
at the following website (http://geschwindlab.neurology.ucla.edu/sites/all/
files/networkplot/ParikshakDevelopmentalCortexNetwork.html).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and four tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.10.031.
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